Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data

Abstract The main aim of this analysis was to investigate time from symptom onset (chronic unexplained dyspnoea [CUD]) to diagnosis of Group 1 pulmonary hypertension (PH)—pulmonary arterial hypertension (PAH)—and to characterize healthcare resource utilization leading up to diagnosis using a nationw...

Full description

Bibliographic Details
Main Authors: Eva‐Maria Didden, Eileen Lee, Julie Wyckmans, Deborah Quinn, Loïc Perchenet
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Pulmonary Circulation
Subjects:
Online Access:https://doi.org/10.1002/pul2.12188
_version_ 1827944810727604224
author Eva‐Maria Didden
Eileen Lee
Julie Wyckmans
Deborah Quinn
Loïc Perchenet
author_facet Eva‐Maria Didden
Eileen Lee
Julie Wyckmans
Deborah Quinn
Loïc Perchenet
author_sort Eva‐Maria Didden
collection DOAJ
description Abstract The main aim of this analysis was to investigate time from symptom onset (chronic unexplained dyspnoea [CUD]) to diagnosis of Group 1 pulmonary hypertension (PH)—pulmonary arterial hypertension (PAH)—and to characterize healthcare resource utilization leading up to diagnosis using a nationwide US claims and an electronic health record (EHR) database from Optum©. Eligible patients were ≥18 years old at first CUD diagnosis (index event) and had a PAH diagnosis on or after index date. Based on administrative codes, PAH was defined as right heart catheterization (RHC), ≥ 2 PAH diagnoses (1 within a year of RHC), and ≥1 post‐RHC prescription for PAH treatment. All values are median (1st quartile–3rd quartile) unless otherwise stated. Of 854,722 patients with CUD in the claims database, 582 (0.1%) had PAH. Time from CUD to PAH diagnosis was 2.26 (0.73–4.22) years. PAH patients experienced 3 (2–4) transthoracic echocardiograms (TTEs), 6 (3–12) specialist visits, and 2 (1–4) hospitalizations during the diagnostic interval. Almost one‐third of patients (29%) waited 10 months or more to have a TTE. Findings from the EHR database were broadly similar. Resource utilization during the diagnostic interval was also analyzed in an overall PH cohort: findings were generally similar to the PAH cohort (2 [1–3] TTEs, 4 [2–9] specialist visits and 2 [1–4] hospitalizations). These data indicate a delay in the diagnostic pathway for PAH, and illustrate the burden associated with PAH diagnosis.
first_indexed 2024-03-13T10:35:33Z
format Article
id doaj.art-e781ce805b7b4374b84b41ac9b627cd1
institution Directory Open Access Journal
issn 2045-8940
language English
last_indexed 2024-03-13T10:35:33Z
publishDate 2023-01-01
publisher Wiley
record_format Article
series Pulmonary Circulation
spelling doaj.art-e781ce805b7b4374b84b41ac9b627cd12023-05-18T06:26:29ZengWileyPulmonary Circulation2045-89402023-01-01131n/an/a10.1002/pul2.12188Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare dataEva‐Maria Didden0Eileen Lee1Julie Wyckmans2Deborah Quinn3Loïc Perchenet4Actelion Pharmaceuticals Ltd Allschwil SwitzerlandJanssen Research & Development Spring House Pennsylvania USAActelion Pharmaceuticals Ltd Allschwil SwitzerlandJanssen Pharmaceuticals, Inc Raritan New Jersey USAActelion Pharmaceuticals Ltd Allschwil SwitzerlandAbstract The main aim of this analysis was to investigate time from symptom onset (chronic unexplained dyspnoea [CUD]) to diagnosis of Group 1 pulmonary hypertension (PH)—pulmonary arterial hypertension (PAH)—and to characterize healthcare resource utilization leading up to diagnosis using a nationwide US claims and an electronic health record (EHR) database from Optum©. Eligible patients were ≥18 years old at first CUD diagnosis (index event) and had a PAH diagnosis on or after index date. Based on administrative codes, PAH was defined as right heart catheterization (RHC), ≥ 2 PAH diagnoses (1 within a year of RHC), and ≥1 post‐RHC prescription for PAH treatment. All values are median (1st quartile–3rd quartile) unless otherwise stated. Of 854,722 patients with CUD in the claims database, 582 (0.1%) had PAH. Time from CUD to PAH diagnosis was 2.26 (0.73–4.22) years. PAH patients experienced 3 (2–4) transthoracic echocardiograms (TTEs), 6 (3–12) specialist visits, and 2 (1–4) hospitalizations during the diagnostic interval. Almost one‐third of patients (29%) waited 10 months or more to have a TTE. Findings from the EHR database were broadly similar. Resource utilization during the diagnostic interval was also analyzed in an overall PH cohort: findings were generally similar to the PAH cohort (2 [1–3] TTEs, 4 [2–9] specialist visits and 2 [1–4] hospitalizations). These data indicate a delay in the diagnostic pathway for PAH, and illustrate the burden associated with PAH diagnosis.https://doi.org/10.1002/pul2.12188chronic unexplained dyspnoeapulmonary arterial hypertensionUS electronic health recordsUS insurance claims
spellingShingle Eva‐Maria Didden
Eileen Lee
Julie Wyckmans
Deborah Quinn
Loïc Perchenet
Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data
Pulmonary Circulation
chronic unexplained dyspnoea
pulmonary arterial hypertension
US electronic health records
US insurance claims
title Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data
title_full Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data
title_fullStr Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data
title_full_unstemmed Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data
title_short Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data
title_sort time to diagnosis of pulmonary hypertension and diagnostic burden a retrospective analysis of nationwide us healthcare data
topic chronic unexplained dyspnoea
pulmonary arterial hypertension
US electronic health records
US insurance claims
url https://doi.org/10.1002/pul2.12188
work_keys_str_mv AT evamariadidden timetodiagnosisofpulmonaryhypertensionanddiagnosticburdenaretrospectiveanalysisofnationwideushealthcaredata
AT eileenlee timetodiagnosisofpulmonaryhypertensionanddiagnosticburdenaretrospectiveanalysisofnationwideushealthcaredata
AT juliewyckmans timetodiagnosisofpulmonaryhypertensionanddiagnosticburdenaretrospectiveanalysisofnationwideushealthcaredata
AT deborahquinn timetodiagnosisofpulmonaryhypertensionanddiagnosticburdenaretrospectiveanalysisofnationwideushealthcaredata
AT loicperchenet timetodiagnosisofpulmonaryhypertensionanddiagnosticburdenaretrospectiveanalysisofnationwideushealthcaredata